Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
with the possibility of renewal. This project addresses the high computational and energy costs of Large Language Models (LLMs) by developing more efficient training and inference methods, particularly
-
, defensive mechanisms and related topics to the safe deployment of systems contain multiple LLM and VLM powered models. You will be responsible for Developing and implementing; capability evaluations, attacks
-
precancers and developing targeted interventions, including vaccines, to intercept them. The project focuses on designing, validating, and preclinically testing neoepitope-based mRNA vaccines to prevent BRCA
-
for applications is 12:00 on Monday 7th July 2025. Interviews will be held as soon as possible thereafter. At the Dunn School we are committed to supporting the professional and career development of our postdocs
-
on the electrosolvation force under development in the group. The planned investigations are primarily experimental in nature, but will proceed in close conjunction with insight from theory and simulations. The ideal
-
closely with a variety of academic, research and professional services colleagues, as well as with students and visitors. As such, you must be an excellent communicator, who is able to develop good working
-
challenges, from reducing our carbon emissions to developing vaccines during a pandemic. Currently located in the Radcliffe Observatory Quarter, Experimental Psychology will be moving to the new, purpose-built
-
are looking for a candidate interested in developing their own research questions in alignment with the interests and skills present in the research team. We are particularly interested in investigating how
-
to help you stay fit and healthy, including discounted membership of the university sports centre on the Iffley Road Personal and professional development - We actively encourage all staff to participate in
-
University of Oxford. The Centre aims to develop the first therapies to stimulate heart repair and regeneration in patients with heart failure, for which there are currently no effective treatments. REACT is a